LipoCoat ISO 13485 Certificate Extended Until March 2025
ISO 13485 Production Scope Expansion
Fabian Stein
January 24, 2022
Introduction
LipoCoat's ISO 13485 Quality Management System certificate has been successfully extended. ISO 13485 Certification ExtendedLipoCoat's ISO 13485 certificate has been extended through March 2025.
ISO 13485 Certification ExtendedLipoCoat's ISO 13485 certificate has been extended through March 2025. Crucially, 'production' has been added to the certified scope for design, development, and production of bio-inspired coatings.
ISO 13485:2016 Audit Reports
Fabian Stein
Chief Business Development Officer (CBDO)
Fabian Stein leads Business Development and Global Sales for the Lipocoat Company, connecting the coating platforms to medical device manufacturers.
Updates
Also interesting
LipoCoat and SonoCoat have earned recognition from leading institutions and regulatory bodies. Our coatings meet the highest standards for biocompatibility and clinical efficacy.
News
LipoCoat celebrates its 10th anniversary and breaks ground on a new production lab in Enschede.
LipoCoat is building a 500-square-meter production lab across from the University of Twente and is marking its tenth anniversary. Constantijn van Oranje started construction.
Publication
SonoCoat® Technology Featured in Scientific Publications
Four independent peer-reviewed studies have evaluated SonoCoat®, from EUS-FNA needles to prostate brachytherapy. What each one tested, and what it found.
Document
When the Needle Disappears: SonoCoat® in Three Clinical Applications
Real-time ultrasound guidance is now standard for CVC placement, yet needles still vanish at steep insertion angles. What SonoCoat® changes in vascular access, biopsy and regional anesthesia.